{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T17:06:37Z","timestamp":1744650397071},"reference-count":25,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2016,11,4]],"date-time":"2016-11-04T00:00:00Z","timestamp":1478217600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100014588","name":"sanofi-pasteur","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100014588","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0165384","type":"journal-article","created":{"date-parts":[[2016,11,4]],"date-time":"2016-11-04T17:32:39Z","timestamp":1478280759000},"page":"e0165384","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":3,"title":["Antibody Persistence and Booster Responses to Split-Virion H5N1 Avian Influenza Vaccine in Young and Elderly Adults"],"prefix":"10.1371","volume":"11","author":[{"given":"Rajeka","family":"Lazarus","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew D.","family":"Snape","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Corinne","family":"Vandermeulen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Merryn","family":"Voysey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karel","family":"Hoppenbrouwers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annick","family":"Hens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre","family":"Van Damme","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie","family":"Pepin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabel","family":"Leroux-Roels","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geert","family":"Leroux-Roels","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew J.","family":"Pollard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2016,11,4]]},"reference":[{"key":"ref1","first-page":"249","article-title":"New Influenza A (H1N1) virus: global epidemiological situation","volume":"84","year":"2009","journal-title":"Wkly Epidemiol Rec"},{"key":"ref2","unstructured":"World Health Organisation Cumulative number of confirmed cases of avian influenza A\/(H5N1) reported to WHO. Available at: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.who.int\/influenza\/human_animal_interface\/H5N1_cumulative_table_archives\/en\/index.html\" xlink:type=\"simple\">http:\/\/www.who.int\/influenza\/human_animal_interface\/H5N1_cumulative_table_archives\/en\/index.html<\/ext-link> Accessed on 7th January 2016"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"f4752","DOI":"10.1136\/bmj.f4752","article-title":"Probable person to person transmission of novel avian influenza A(H7N9) virus in Eastern China: epidemiological investigation","volume":"347","author":"X Qi","year":"2013","journal-title":"BMJ"},{"issue":"6088","key":"ref4","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1126\/science.1222526","article-title":"The potential for respiratory droplet-transmissible A\/H5N1 influenza virus to evolve in a mammalian host","volume":"336","author":"CA Russell","year":"2012","journal-title":"Science"},{"issue":"10","key":"ref5","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/S1473-3099(08)70232-9","article-title":"Stockpiling pre-pandemic influenza vaccines: a new cornerstone of pandemic preparedness plans","volume":"8","author":"LC Jennings","year":"2008","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"ref6","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.vaccine.2014.11.018","article-title":"Immunogenicity of heterologous H5N1 influenza booster vaccination 6 or 18 months after primary vaccination in adults: A randomized controlled clinical trial","volume":"33","author":"JM Langley","year":"2015","journal-title":"Vaccine"},{"issue":"4","key":"ref7","doi-asserted-by":"crossref","first-page":"e95496","DOI":"10.1371\/journal.pone.0095496","article-title":"Heterologous prime-boost vaccination with MF59-adjuvanted H5 vaccines promotes antibody affinity maturation towards the hemagglutinin HA1 domain and broad H5N1 cross-clade neutralization","volume":"9","author":"S Khurana","year":"2014","journal-title":"PLoS One"},{"issue":"49","key":"ref8","doi-asserted-by":"crossref","first-page":"6918","DOI":"10.1016\/j.vaccine.2009.08.110","article-title":"Humoral and cellular immune response to split virion H5N1 influenza vaccine in young and elderly adults","volume":"27","author":"I Leroux-Roels","year":"2009","journal-title":"Vaccine"},{"key":"ref9","unstructured":"Committee for Human Medicinal Products. Guideline on Influezna Vaccines Prepared From Viruses With The Potential To Cause A Pandemic And Intended For Use Outside Of The Core Dossier Context. 24th January 2007. Available at <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/emea.europa.eu\" xlink:type=\"simple\">http:\/\/emea.europa.eu<\/ext-link>"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1086\/595832","article-title":"Antibody Persistence after 2-Dose Priming and Booster Response to a Third Dose of an Inactivated, Adjuvanted, Whole-Virion H5N1 Vaccine","volume":"199","author":"JT Lin","journal-title":"J Infect Dis"},{"issue":"12","key":"ref11","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1093\/infdis\/jir172","article-title":"Dose-sparing H5N1 A\/Indonesia\/05\/2005 pre-pandemic influenza vaccine in adults and elderly adults: a phase III, placebo-controlled, randomized study","volume":"203","author":"JM Langley","year":"2011","journal-title":"J Infect Dis"},{"issue":"37","key":"ref12","doi-asserted-by":"crossref","first-page":"6408","DOI":"10.1016\/j.vaccine.2011.04.072","article-title":"Immunological priming induced by a two-dose series of H5N1 influenza antigen, administered alone or in combination with two different formulations of AS03 adjuvant in adults: results of a randomised single heterologous booster dose study at 15 months","volume":"29","author":"G Risi","year":"2011","journal-title":"Vaccine"},{"issue":"8","key":"ref13","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1093\/infdis\/jiq174","article-title":"Immunogenicity profile of a 3.75-\u03bcg hemagglutinin pandemic rH5N1 split virion ASO2-adjuvanted vaccine in elderly persons: a randomized trial","volume":"203","author":"S Hejimans","year":"2011","journal-title":"J Infect Dis"},{"issue":"2","key":"ref14","doi-asserted-by":"crossref","first-page":"e4384","DOI":"10.1371\/journal.pone.0004384","article-title":"MF59\u00ae-Adjuvanted H5N1 Vaccine Induces Immunologic Memory and Heterotypic Antibody Responses in Non-Elderly and Elderly Adults","volume":"4","author":"A Banzhoff","year":"2009","journal-title":"PLoS ONE"},{"issue":"1","key":"ref15","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3201\/eid1401.061283","article-title":"Cross-subtype immunity against avian influenza in persons recently vaccinated for influenza","volume":"14","author":"C Gioia","year":"2008","journal-title":"Emerg Infect Dis"},{"issue":"1","key":"ref16","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1750-2659.2012.00349.x","article-title":"An assessment of prime-boost vaccination schedules with AS03A-adjuvanted prepandemic H5N1 vaccines: a randomized study in European adults","volume":"7","author":"P Gillard","year":"2013","journal-title":"Influenza and other Respiratory Viruses"},{"issue":"3","key":"ref17","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.vaccine.2009.10.017","article-title":"Priming with AS03 A-adjuvanted H5N1 influenza vaccine improves the kinetics, magnitude and durability of the immune response after a heterologous booster vaccination: an open non-randomised extension of a double-blind randomised primary study","volume":"28","author":"I Leroux-Roels","year":"2010","journal-title":"Vaccine"},{"issue":"19","key":"ref18","doi-asserted-by":"crossref","first-page":"7962","DOI":"10.1073\/pnas.0903181106","article-title":"Fast rise of broadly cross-reactive antibodies after boosting long-lived human memory B cells primed by an MF59 adjuvanted prepandemic vaccine","volume":"106","author":"G Gallia","year":"2009","journal-title":"PNAS"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S1473-3099(10)70296-6","article-title":"Immunogenicity and safety of a two-dose schedule of whole-virion and AS03A-adjuvanted 2009 infl uenza A (H1N1) vaccines: a randomised, multicentre, age-stratified, head-to-head trial","volume":"11","author":"K Nicholson","year":"2011","journal-title":"Lancet Infect Dis"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1086\/590913","article-title":"An Adjuvanted, Low-Dose, Pandemic Influenza A(H5N1) Vaccine Candidate Is Safe, Immunogenic,and Induces Cross-Reactive Immune Responses in Healthy Adults","volume":"198","author":"K Levie","year":"2008","journal-title":"J Infect Dis"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/S0140-6736(07)61297-5","article-title":"Antigen sparing and cross-reactive immunity with an adjuvanted rH5N1 prototype pandemic influenza vaccine: a randomized controlled trial","volume":"370","author":"I Leroux-Roels","year":"2007","journal-title":"Lancet"},{"issue":"2","key":"ref22","doi-asserted-by":"crossref","first-page":"e1665","DOI":"10.1371\/journal.pone.0001665","article-title":"Leroux-Roels G Broad Clade 2 Cross-Reactive Immunity Induced by an Adjuvanted Clade 1 rH5N1 Pandemic Influenza Vaccine","volume":"3","author":"I Leroux-Roels","year":"2008","journal-title":"Plos"},{"issue":"8","key":"ref23","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1086\/597401","article-title":"Immunogenicity, safety, and cross-reactivity of an inactivated, adjuvanted, prototype pandemic influenza (H5N1) vaccine: a phase II, double-blind, randomized trial","volume":"48","author":"J Wu","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"37","key":"ref24","doi-asserted-by":"crossref","first-page":"5091","DOI":"10.1016\/j.vaccine.2009.06.057","article-title":"Safety and immunogenicity of a subvirion inactivated influenza A\/H5N1 vaccine with or without aluminum hydroxide among healthy elderly adults","volume":"27","author":"RC Brady","year":"2009","journal-title":"Vaccine"},{"issue":"9523","key":"ref25","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1016\/S0140-6736(06)68656-X","article-title":"Safety and immunogenicity of an inactivated split-virion influenza A\/Vietnam\/1194\/2004 (H5N1) vaccine: phase I randomised trial","volume":"367","author":"JL Bresson","year":"2006","journal-title":"Lancet"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0165384","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T08:53:57Z","timestamp":1589705637000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0165384"}},"subtitle":[],"editor":[{"given":"Ray","family":"Borrow","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2016,11,4]]},"references-count":25,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2016,11,4]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0165384","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,4]]}}}